DCC protein expression in clear cell renal cell carcinoma

BJU International

Volumn 93, Issue 6, 2004, Pages 867-869

  Dekel, Y ^a   Kugel, V ^a,b   Livne, P M ^a,b   Gal, R ^a,b   Koren, R ^a,b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

DCC expression; Prognosis; RCC; Survival

Indexed keywords

BIOCHEMICAL MARKER; DELETED IN COLORECTAL CANCER PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CAUSE OF DEATH; CLEAR CELL CARCINOMA; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; CELL ADHESION MOLECULES; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; RECEPTORS, CELL SURFACE; SURVIVAL ANALYSIS; TUMOR SUPPRESSOR PROTEINS;

EID: 1942509682     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2003.04730.x     Document Type: Article

References (36)

1. Wingo PA, Tong T, Bolden S. Cancer Statistics. CA Cancer J 1995; 45: 8
2. Mancilla-Jimenez R. Papillary renal cell carcinoma, a clinical, radiologic and pathologic study of 34 cases. Cancer 1976; 38: 246-70
3. DeKernion JB, Mukamel E. Selection of initial therapy for renal cell carcinoma. Cancer 1987; 60: 539-42
4. Muss HB. The role of biological response modifiers in metastatic renal cell carcinoma. Sem Oncol Suppl 1988; 15: 30
5. Richie AWS. Current treatment approaches to renal cell carcinoma - the role of surgery. In Progress in the Treatment of Renal Cell Carcinoma. Proceeding of the National Symposium, Queens College, Cambridge, Massachusetts 1989: 1-11
6. Robson CJ. Radical nephrectomy for renal cell carcinoma. J Urol 1963; 89: 37-41
7. Patel NP, Lavengood RW. Renal cell carcinoma. Natural history and results of treatment. J Urol 1978; 119: 722-7
8. Maldazys JD, deKernion JB. Prognostic factors in metastatic renal carcinoma. J Urol 1986; 136: 376-80
9. Guinan PD, Vogelzang NJ, Freman AM. Renal cell carcinoma: tumor size, stage and survival. J Urol 1995; 153: 901-5
10. Medeiros LJ, Gelb AB, Weiss LM. Renal cell carcinoma, prognostic significance of morphologic parameters in 121 cases. Cancer 1988; 61: 1639-44
11. Fuhrman SA, Lasky LC, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 1992; 6: 655-60
12. DeKernion JB, Derry D. The diagnosis and treatment of renal cell carcinoma. Cancer 1980; 45: 1947-53
13. Myers GH, Fehrenbaker LG, Kellais PP. Prognostic significance of renal vein invasion by hypernephroma. J Urol 1968; 100: 420-3
14. Skinner DG, Pfister RF, Colvin R. Extension of renal cell carcinoma into the vena cava. The rationale for aggressive surgical management. J Urol 1972; 107: 711-4
15. Selli C, Hinshaw WM, Woodard BH, Paulson DF. Stratification of risk factors in renal cell carcinoma. Cancer 1983; 52: 899-903
16. Skinner DG, Colvin RB, Vermillion CD, Pfister RC, Leadbetter WF. Diagnosis and management of renal cell carcinoma a clinical and pathological study of 309 cases. Cancer 1971; 28: 1165-70
17. Hatcher PA, Anderson EE, Paulson DF, Carson CC, Roberson JE. Surgical management and prognosis of renal cell carcinoma invading the vena cava. J Urol 1991; 145: 20-5
18. Sanchez De La Muela P, Zudaire JJ, Robles IE et al. Renal cell carcinoma, vena cava invasion and prognostic factors. Eur Urol 1991; 19: 284-9
19. Jen J, Kim H. Allelic loss of chromosome 18q and prognosis in colorectal cancer. N Engl J Med 1994; 331: 213-21
20. Saito M, Yamaguchi A, Goi T et al. Expression of DCC protein in colorectal tumors and its relation to tumor progression and metastases. Oncology 1999; 56: 134-41
21. Reymond MA, Dworak O, Remke S, Hohenberger W, Kirchner T, Kockerling F. DCC protein as a predictor of distant metastases after curative surgery for rectal cancer. Dis Colon Rectum 1998; 41: 755-60
22. Jessup JM, Loda M. Prognostic markers in rectal carcinoma. Semin Surg Oncol 1998 2002; 15: 131-40
23. Li X, Saint-Cyr-Proulx E, Aktories K, Lamarche-Vane N. Rad and Cdc42 but not RhoA or Rho-kinase activities are required for neurite outgrowth induced by the Netrin-1 receptor DCC (deleted in colorectal cancer) in N1E-115 neuroblastoma cells. J Biol Chem 2002; 277: 15207-14
24. Wang M, Lu R, Fang D. The possible role of loss of heterozygosity at APC, MCC and DCC genetic loci in esophageal carcinoma. Zhonghua Zhong Liu Za Zhi 1999; 21: 16-28
25. Hara A, Saegusa M, Mikami T, Okayasu I. Loss of DCC expression in astrocytomas: relation to p53 abnormalities, cell kinetics, and survival. J Clin Pathol 2001; 54: 860-5
26. Kong XT, Choi SH, Bessho F et al. Codon 201 (Gly) polymorphic type of the DCC gene is related to disseminated neuroblastoma. Neoplasia 2001; 3: 267-72
27. Graziano F, Cascinu S, Staccioli MP et al. Potential role and chronology of abnormal expression of the Deleted in Colon Cancer (DCC) and the p53 proteins in the development of gastric cancer. BMC Cancer 2001; 1: 9-12
28. Yin Z, Babaian RJ, Troncoso P et al. Limiting the location of putative human prostate cancer tumor suppressor genes on chromosome 18q. Oncogene 2001; 20: 2273-80
29. Buschges R, Bostrom J, Wolter M et al. Analysis of human meningiomas for aberrations of the MADH2, MADH4, APM-1 and DCC tumor suppressor genes on the long arm of chromosome 18. Int J Cancer 2001; 15: 551-4
30. Cong WM, Bakker A, Swalsky PA et al. Multiple genetic alterations involved in the tumorigenesis of Human cholangiocarcinoma: a molecular genetic and clinicopathological study. J Cancer Res Clin Oncol 2001; 127: 187-92
31. Forced C, Ye X, Granger L et al. The dependence receptor DCC (deleted in colorectal cancer) defines an alternative mechanism for caspase activation. Proc Natl Acad Sci Usa 2001; 98: 3416-21
32. Aguiari G, Martinello R, Casaro D et al. LOH of chromosome 6q compared with LOH of 17q and 18q in ovarian cancers: relationship to p53 expression and clinicopathological findings. Int J Gynecol Cancer 1999; 9: 147-55
33. World Health Organization. International Histologic Classification of Tumors, 2nd edn. Berlin: Spring Verlag, 1990
34. Jiang F, Desper R, Papadimitriou CH et al. Construction of evolutionary tree models for renal cell carcinoma from comparative genomic hybridization data. Cancer Res 2000; 60: 6503-9
35. Vogelstein B, Fearon ER, Hamilton SR et al. Genetic alterations during colorectal tumor development. N Engl J Med 1988; 319: 525-32
36. Kondo K, Yak M, Kobayashi K et al. PTEN/MMAC1/TEP1 mutations in human primary renal-cell carcinomas and Renal carcinoma cell lines. Int J Cancer 2001; 91: 219-24